Inhibition of cathepsin L-like proteases by cathepsin V propeptide

Biological Chemistry

Volumn 388, Issue 5, 2007, Pages 541-545

  Burden, Roberta E ^a   Snoddy, Philip ^b   Jefferies, Caroline A ^c   Walker, Brian ^a   Scott, Christopher J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b FUSION ANTIBODIES LTD   (United Kingdom)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Chromatography; Kinetics; Prodomain; Recombinant; Refold; Zymogen

Indexed keywords

CATHEPSIN L; CATHEPSIN V PROPEPTIDE; PEPTIDE DERIVATIVE; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; ENZYME PURIFICATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

CATHEPSIN B; CATHEPSINS; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION; HUMANS; PEPTIDE FRAGMENTS;

EID: 34249106050     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.053     Document Type: Article

References (22)

1. Adachi, W., Kawamoto, S., Ohno, I., Nishida, K., Kinoshita, S., Matsubara, K., and Okubo, K. (1998). Isolation and characterization of human cathepsin V: a major proteinase in corneal epithelium. Invest. Ophthalmol. Vis. Sci. 39, 1789-1796.
2. Baker, D., Sohl, J.L., and Agard, D.A. (1992). A protein-folding reaction under kinetic control. Nature 56, 263-265.
3. Billington, C.J., Mason, P., Magny, M.C., and Mort, J.S. (2000). The slow-binding inhibition of cathepsin K by its propeptide. Biochem. Biophys. Res. Commun. 276, 924-929.
4. Bromme, D., Li, Z., Barnes, M., and Mehler, E. (1999). Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry 38, 2377-2385.
5. Buhling, F., Fengler, A., Brandt, W., Welte, T., Ansorge, S., and Nagler, D.K. (2000). Review: novel cysteine proteases of the papain family. Adv. Exp. Med. Biol. 477, 241-254.
6. Carmona, E., Dufour, E., Plouffe, C., Takebe, S., Mason, P., Mort, J.S., and Menard, R. (1996). Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry 35, 8149-8157.
7. Fox, T., de Miguel, E., Mort, J.S., and Storer, A.C. (1992). Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry 31, 12571-12576.
8. Groves, M.R., Coulombe, R., Jenkins, J., and Cygler, M. (1998). Structural basis for specificity of papain-like cysteine protease proregions toward their cognate enzymes. Proteins 32, 504-514.
9. Guay, J., Falgueyret, J.P., Ducret, A., Percival, M.D., and Mancini, J.A. (2000). Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides. Eur. J. Biochem. 267, 6311-6318.
10. Hagemann, S., Gunther, T., Dennemarker, J., Lohmuller, T., Bromme, D., Schule, R., Peters, C., and Reinheckel, T. (2004). The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles. Eur. J. Cell. Biol. 83, 775-780.
11. Itoh, R., Kawamoto, S., Adachi, W., Kinoshita, S., and Okubo, K. (1999). Genomic organization and chromosomal localization of the human cathepsin L2 gene. DNA Res. 6, 137-140.
12. Karrer, K.M., Peiffer, S.L., and DiTomas, M.E. (1993). Two distinct gene subfamilies within the family of cysteine protease genes. Proc. Natl. Acad. Sci. USA 90, 3063-3067.
13. Maubach, G., Schilling, K., Rommerskirch, W., Wenz, I., Schultz, J.E., Weber, E., and Wiederanders, B. (1997). The inhibition of cathepsin S by its propeptides-specificity and mechanism of action. Eur. J. Biochem. 250, 745-750.
14. Morrison, J.F. and Walsh, C.T. (1988). The behaviour and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61, 201-301.
15. Nishimura, Y., Kawabata, T., and Kato, K. (1988). Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch. Biochem. Biophys. 261, 64-71.
16. Puente, X.S., Sanchez, L.M., Overall, C.M., and Lopez-Otin, C. (2003). Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544-558.
17. Santamaria, I., Velasco, G., Cazorla, M., Fueyo, A., Campo, E., and Lopez-Otin, C. (1998). Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res. 58, 1624-1630.
18. Shi, G.P., Villadangos, J.A., Dranoff, G., Small, C., Gu, L., Haley, K.J., Riese, R., Ploegh, H.L., and Chapman, H.A. (1999). Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10, 197-206.
19. Sinha, D., Bakhshi, M., and Vora, R. (1994). Ligand binding assays with recombinant proteins refolded on an affinity matrix. Biotechniques 17, 509-514.
20. Sivaraman, J., Lalumiere, M., Menard, R., and Cygler, M. (1999). Crystal structure of wild-type human procathepsin K. Protein Sci. 8, 283-290.
21. Taylor, M.A., Briggs, G.S., Baker, K.C., Cummings, N.J., Pratt, K.A., Freedman, R.B., and Goodenough, P.W. (1995). Expression of the pro-regions of papain and papaya proteinase IV in Escherichia coli and their inhibition of mature cysteine proteinases. Biochem. Soc. Trans. 23, 80S.
22. Tolosa, E., Li, W., Yasuda, Y., Wienhold, W., Denzin, L.K., Lautwein, A., Driessen, C., Schnorrer, P., Weber, E., Stevanovic, S., et al. (2003). Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J. Clin. Invest. 112, 517-526.